MediPharm Labs
(OTCQB:MEDIF)
$0.0604
-0.0006[-0.98%]
At close: May 9
Q1 2024 Earnings in 6 days from now on Wed May 15th, before the market open
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

MediPharm Labs Stock (OTC:MEDIF), Quotes and News Summary

MediPharm Labs Stock (OTC: MEDIF) stock price, news, charts, stock research, profile.

Open$0.060
Close$0.060
Volume / Avg.200.117K / 112.417K
Day Range0.058 - 0.063
52 Wk Range0.040 - 0.077
Market Cap$24.405M
P/E Ratio-
Dividend Yield-
ExchangeOTC
RSI
0
Short Interest-
Days to Cover12.64

Recent News

This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses
Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday its financial results for the full year and three months ended Dec. 31, 2023. Net revenue grew to CA$33 million ($24.3 million), from CA$22.1 million in 2022, representing roughly a 50% year-over-year increase. "Over the years we have invested in our infrastructure as a high quality and high-capacity pharmaceutical grade manufacturer, allowing us to grow sales with new opportunities and markets, without additional investment into capital or resources," David Pidduck said. "We are proud of the work completed in 2023 and excited about the future of MediPharm Labs."
Jelena Martinovic
Canadian CBD-Focused Pharma Co. Gets Green Light To Produce Medical Marijuana In Brazil
Canada's MediPharm Labs has received a GMP certification from the Brazilian governing body, ANVISA. The approval allows for the production of active pharmaceutical ingredients (APIs) and end products for the Brazilian medical cannabis market. MediPharm has already received GMP certifications from the US FDA, the European Union, and Australia's TGA, and holds a drug establishment license from Health Canada. The Brazilian medical cannabis market is projected to reach CAD380m (USD282m) by 2025, according to industry forecasts. MediPharm Labs, which already produces two medical cannabis products with full ANVISA authorization for the Brazilian market, is potentially set for further product authorizations through the regulatory body, according to reports.
Jelena Martinovic
Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024
This month, the Indigenous Cannabis Industry Association held its first Indigenous Cannabis Regulators roundtable, bringing together Indigenous Cannabis Regulators from Tribal Nations and Indigenous-led cannabis organizations across the United States to discuss community-oriented approaches to hemp and cannabis regulation.
Jelena Martinovic
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
MEDIF

FAQ

Q

How do I buy MediPharm Labs (MEDIF) stock?

A

You can purchase shares of MediPharm Labs (OTCQB: MEDIF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are MediPharm Labs's (MEDIF) competitors?

A

There are no as such competitors for MediPharm Labs.

Q

What is the target price for MediPharm Labs (MEDIF) stock?

A

There is no analysis for MediPharm Labs.

Q

Current Stock Price for MediPharm Labs (MEDIF)?

A

The stock price for MediPharm Labs (OTCQB: MEDIF) is $0.0604 last updated Today at May 9, 2024 at 3:10 PM EDT.

Q

Does MediPharm Labs (MEDIF) pay a dividend?

A

There are no upcoming dividends for MediPharm Labs.

Q

When is MediPharm Labs (OTCQB:MEDIF) reporting earnings?

A

MediPharm Labs’s Q1 earnings are confirmed for Wednesday, May 15, 2024.

Q

Is MediPharm Labs (MEDIF) going to split?

A

There is no upcoming split for MediPharm Labs.

Q

What sector and industry does MediPharm Labs (MEDIF) operate in?

A

MediPharm Labs is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQB.